P178 Home remote-monitored auto-NIV: realistic provision and improved projected admission-free survival in patients with chronic hypercapnic COPD

Toellner, Hannah; McDowell, G; Burns, JE; Sumowski, M; Lowe, David J.; Carlin, C. M.

doi:10.1136/thorax-2018-212555.335

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous NHS GG&C studies 8,16 , combined with internal audit data (indicating that 80% of patients have direct or daily smartphone, tablet, or web access) indicate that recruitment of 400 patients across a 12-month period is feasible, and likely to provide adequate data to conduct meaningful primary and secondary endpoint analyses.…”

Section: Study Methods and Analysismentioning

confidence: 99%

“…There has so far been relatively limited success at providing home NIV for COPD patients in the UK, within existing service models. However, in NHS GG&C we have been successful in delivering home NIV to eligible COPD patients, utilising digital technologies routinely available (adaptive “auto-NIV” modes, 2-way remote monitoring via ResMed AirView platform), with outcomes in our service adoption pilot study matching those from the HOT-HMV randomised clinical trial 16,17 . The challenge is to extend the evidence for this approach and obtain a service adoption playbook to enable this to be adapted and delivered at scale, by other clinical teams, within COPD integrated care.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Remote-management of COPD: Evaluating Implementation of Digital Innovation to Enable Routine Care (RECEIVER) – Protocol for a feasibility and service adoption observational cohort study

Taylor

McDowell

Lua

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

Introduction: Reduction in exacerbations and hospitalisations are the outcomes rated as most important by COPD patients. Most COPD management is currently based on a reactive approach, and delays in recognising treatable opportunities underpin COPD care-quality gaps. Innovations which can empower patient self-management, facilitate integrated clinical care and support delivery of evidence-based treatment interventions are urgently required. Methods and analysis: The RECEIVER trial is a prospective observational cohort hybrid implementation and effectiveness study that will test the adoption of a digital service model for "high-risk" COPD patients and evaluate the performance of this approach versus current standards of care. Patients with a recent severe exacerbation and/or COPD-OSA overlap or chronic hypercapnic respiratory failure requiring home NIV or CPAP, with access to smartphone, tablet or computer will be recruited into the study and enrolled into the digital service. Study endpoints will examine patient utilisation, clinical service impact and clinical outcomes compared to historical and contemporary COPD control patient data. The digital infrastructure for this support of routine clinical care will also provide a foundation to explore the feasibility of approaches to predict outcomes and exacerbations in COPD patients through machine-learning analysis. Ethics and dissemination: Ethical approval for this clinical trial has been obtained from the West of Scotland Research Ethics Service (WoSRES). The trial will commence in September 2019 for a duration of 2 years. Results will be presented at local, national and international meetings, as well as submission for publication to peer reviewed journals. Trial registration number NCT04240353

show abstract

Section: Study Methods and Analysismentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Remote-management of COPD: Evaluating Implementation of Digital Innovation to Enable Routine Care (RECEIVER) – Protocol for a feasibility and service adoption observational cohort study

Taylor

McDowell

Lua

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

show abstract

“… 20 NHS GG&C has successfully matched the outcomes from the HOT-HMV randomised clinical trial in our service adoption pilot delivering home NIV to eligible patients with COPD, using routinely available digital technologies (adaptive ‘auto-NIV’ modes, two-way remote monitoring via ResMed AirView platform). 21 22 The challenge is to extend the evidence for this approach and obtain a service adoption playbook to enable this to be adapted and delivered at scale, by other clinical teams, within COPD integrated care.…”

Section: Introductionmentioning

confidence: 99%

Remote-Management of COPD: Evaluating the Implementation of Digital Innovation to Enable Routine Care (RECEIVER): the protocol for a feasibility and service adoption observational cohort study

et al. 2021

View full text Add to dashboard Cite

IntroductionReductions in exacerbation and hospitalisations are the outcomes rated as most important by people with chronic obstructive pulmonary disease (COPD). Most COPD management is currently based on a reactive approach, and delays in recognising treatable opportunities underpin COPD care quality gaps. Innovations that empower COPD self-management, facilitate integrated clinical care and support delivery of evidence-based treatment interventions are urgently required.Methods and analysisThe Remote-Management of COPD: Evaluating the Implementation of Digital Innovation to Enable Routine Care trial is a prospective observational cohort hybrid implementation and effectiveness study that will explore the adoption of a digital service model for people with ‘high-risk’ COPD and evaluate the feasibility of this approach versus current standards of care. People with COPD, who have had recent severe exacerbation and/or COPD–obstructive sleep apnoea overlap or chronic hypercapnic respiratory failure requiring home non-invasive ventilation (NIV) or continuous positive airway pressure (CPAP), with internet access will be recruited into the study and enrolled into the digital service.Study endpoints will examine participant utilisation, clinical service impact and clinical outcomes compared with historical and contemporary control patient data. The digital infrastructure will also provide a foundation to explore the feasibility of approaches to predict outcomes and exacerbation in people with COPD through machine learning analysis.Ethics and disseminationEthical approval for this clinical trial has been obtained from the West of Scotland Research Ethics Service. The trial will commence in September 2019 for a duration of 2 years. Results will be presented at local, national and international meetings, as well as submission for publication to peer-reviewed journals.Trial registration numberNCT04240353.

show abstract

P178 Home remote-monitored auto-NIV: realistic provision and improved projected admission-free survival in patients with chronic hypercapnic COPD

Cited by 2 publications

References 0 publications

Remote-management of COPD: Evaluating Implementation of Digital Innovation to Enable Routine Care (RECEIVER) – Protocol for a feasibility and service adoption observational cohort study

Remote-management of COPD: Evaluating Implementation of Digital Innovation to Enable Routine Care (RECEIVER) – Protocol for a feasibility and service adoption observational cohort study

Remote-Management of COPD: Evaluating the Implementation of Digital Innovation to Enable Routine Care (RECEIVER): the protocol for a feasibility and service adoption observational cohort study

Contact Info

Product

Resources

About